PRKAA1 and central nervous system cancer: Moreover, MAGEA6 knockdown restored AMPKα1 expression and inhibited glioma cell survival via mTORC1 inactivation as well as glioma xenograft growth [112], while AMPKα1 silencing ameliorated glioma cell death.